You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Teva Pharms Usa Inc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for TEVA PHARMS USA INC, and what generic and branded alternatives to TEVA PHARMS USA INC drugs are available?

TEVA PHARMS USA INC has twenty-seven approved drugs.

There are fourteen tentative approvals on TEVA PHARMS USA INC drugs.

Summary for Teva Pharms Usa Inc

US Patents:	0
Tradenames:	26
Ingredients:	26
NDAs:	27

Drugs and US Patents for Teva Pharms Usa Inc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Pharms Usa Inc	LEVOTHYROXINE SODIUM	levothyroxine sodium	CAPSULE;ORAL	211369-003	Apr 16, 2021		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Teva Pharms Usa Inc	RISPERIDONE	risperidone	INJECTABLE;INTRAMUSCULAR	214068-002	Dec 5, 2023	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Teva Pharms Usa Inc	MIFEPRISTONE	mifepristone	TABLET;ORAL	211436-001	Aug 3, 2020	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Teva Pharms Usa Inc	SORAFENIB TOSYLATE	sorafenib tosylate	TABLET;ORAL	209567-001	Nov 12, 2020	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Teva Pharms Usa Inc	APREMILAST	apremilast	TABLET;ORAL	211897-003	Aug 18, 2022		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for TEVA PHARMS USA INC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	for Injection	200 mcg/vial	➤ Subscribe	2015-05-01
➤ Subscribe	for Injection	100 mcg/vial and 500 mcg/vial	➤ Subscribe	2015-04-14

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.